• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印戒细胞型结直肠癌:我们是否需要改进治疗方案?

Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm?

作者信息

Tamhankar Anup Sunil, Ingle Parag, Engineer Reena, Bal Munita, Ostwal Vikas, Saklani Avanish

机构信息

Anup Sunil Tamhankar, Parag Ingle, Department of Surgical Oncology, Tata Memorial Centre, Mumbai, Maharashtra 400012, India.

出版信息

World J Gastrointest Oncol. 2016 Dec 15;8(12):819-825. doi: 10.4251/wjgo.v8.i12.819.

DOI:10.4251/wjgo.v8.i12.819
PMID:28035252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5156848/
Abstract

AIM

To elaborate about this peculiar variant from a tertiary cancer center from India.

METHODS

It's a retrospective study (2011-2014) of all patients diagnosed with signet ring colo-rectal cancer (SRCC). Various clinico-pathological variables were studied.

RESULTS

One hundred and seventy consecutive patients with SRCC were diagnosed (11.4% of all colorectal cancers). Median Age of the cohort was 41 years. Most common location was recto-sigmoid area (54.7%). Majority patients presented in stage III and IV (91.2%). Most of the stage IV patients had isolated peritoneal metastases (86.5%). Colonic tumors had higher incidence of peritoneal metastases (91.8% 83.3%) as well as isolated peritoneal recurrences (37.5% 16.7%) than rectal primaries. Thirty-seven point five percent of patients recurred after curative surgery. Amongst them 63.63% patients had isolated peritoneal recurrences. Circumferential resection margin (CRM) was involved in 17.9% patients. Median relapse free survival (RFS) and overall survival (OS) of the cohort were 14.9 and 18.13 mo respectively. CRM involvement, colonic primary were associated with poorer RFS and OS.

CONCLUSION

SRCC has predilection for peritoneal dissemination. More aggressive and/or extended chemotherapy schedules as well as prophylactic hyperthermic intra-peritoneal chemotherapy at the time of primary surgery may be attempted in these patients.

摘要

目的

阐述来自印度一家三级癌症中心的这种特殊变体。

方法

这是一项对所有诊断为印戒细胞型结直肠癌(SRCC)患者的回顾性研究(2011 - 2014年)。研究了各种临床病理变量。

结果

连续诊断出170例SRCC患者(占所有结直肠癌的11.4%)。该队列的中位年龄为41岁。最常见的部位是直肠乙状结肠区域(54.7%)。大多数患者表现为Ⅲ期和Ⅳ期(91.2%)。大多数Ⅳ期患者有孤立性腹膜转移(86.5%)。与直肠原发性肿瘤相比,结肠肿瘤的腹膜转移发生率(91.8%对83.3%)以及孤立性腹膜复发率(37.5%对16.7%)更高。37.5%的患者在根治性手术后复发。其中63.63%的患者有孤立性腹膜复发。17.9%的患者环周切缘(CRM)受累。该队列的中位无复发生存期(RFS)和总生存期(OS)分别为14.9个月和18.13个月。CRM受累、结肠原发性肿瘤与较差的RFS和OS相关。

结论

SRCC倾向于腹膜播散。对于这些患者,可尝试更积极和/或延长的化疗方案以及在初次手术时进行预防性腹腔内热化疗。

相似文献

1
Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm?印戒细胞型结直肠癌:我们是否需要改进治疗方案?
World J Gastrointest Oncol. 2016 Dec 15;8(12):819-825. doi: 10.4251/wjgo.v8.i12.819.
2
Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade, and stage.普通结直肠癌与原发性结直肠印戒细胞癌的比较:年龄、性别、分级和分期匹配的研究
Dis Colon Rectum. 1999 Dec;42(12):1618-25. doi: 10.1007/BF02236218.
3
Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology.印戒细胞组织学类型的结直肠癌腹膜转移癌患者接受细胞减灭术和腹腔热灌注化疗后的预后较差。
J Surg Oncol. 2015 Feb;111(2):237-42. doi: 10.1002/jso.23784. Epub 2014 Sep 5.
4
Outcomes of Definitive Treatment of Signet Ring Cell Carcinoma of the Rectum: Is Minimal Invasive Surgery Detrimental in Signet Ring Rectal Cancers?直肠印戒细胞癌根治性治疗的结果:微创手术对直肠印戒细胞癌有害吗?
Indian J Surg Oncol. 2020 Dec;11(4):597-603. doi: 10.1007/s13193-020-01142-2. Epub 2020 Aug 3.
5
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.结直肠腹膜转移的细胞减灭术和腹腔热灌注化疗的演变:8 年单中心经验。
Dis Colon Rectum. 2019 Oct;62(10):1195-1203. doi: 10.1097/DCR.0000000000001456.
6
Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.结直肠印戒细胞癌:受益于辅助化疗,但预后不良因素。
Int J Cancer. 2015 Jan 15;136(2):333-9. doi: 10.1002/ijc.28981. Epub 2014 May 28.
7
Clinical Analysis of Primary Colorectal Signet-Ring Cell Carcinoma.原发性结直肠印戒细胞癌的临床分析。
Clin Colorectal Cancer. 2018 Mar;17(1):e39-e44. doi: 10.1016/j.clcc.2017.06.010. Epub 2017 Jul 8.
8
Primary colorectal signet-ring cell carcinoma in Singapore.新加坡原发性结直肠癌印戒细胞癌
ANZ J Surg. 2001 Dec;71(12):703-6. doi: 10.1046/j.1445-1433.2001.02269.x.
9
Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.胃黏液腺癌与印戒细胞癌患者的临床病理及预后特征比较
Curr Med Res Opin. 2017 Jan;33(1):109-116. doi: 10.1080/03007995.2016.1239192. Epub 2016 Oct 18.
10
Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.结直肠癌印戒细胞癌的预后及其与伴有印戒细胞的黏液腺癌的鉴别。一项对比研究。
Pathol Oncol Res. 2018 Jul;24(3):609-616. doi: 10.1007/s12253-017-0283-6. Epub 2017 Aug 7.

引用本文的文献

1
Case report: Coexistence of rectal signet ring cell carcinoma with neuroendocrine components.病例报告:直肠印戒细胞癌合并神经内分泌成分
BMC Geriatr. 2025 May 28;25(1):382. doi: 10.1186/s12877-025-06037-x.
2
Systematic review of risk factors, prognosis, and management of colorectal signet-ring cell carcinoma.结直肠癌印戒细胞癌危险因素、预后及治疗的系统评价
World J Gastrointest Oncol. 2024 May 15;16(5):2141-2158. doi: 10.4251/wjgo.v16.i5.2141.
3
Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers.局部晚期直肠腺癌(包括印戒细胞癌和黏液腺癌)全剂量同期放化疗的新辅助治疗(TNT)。
J Gastrointest Cancer. 2024 Mar;55(1):307-317. doi: 10.1007/s12029-023-00941-4. Epub 2023 Jul 21.
4
An Extremely Rare Case of Rectal Signet Ring Cell Carcinoma.一例极其罕见的直肠印戒细胞癌病例。
Gastroenterology Res. 2022 Apr;15(2):106-111. doi: 10.14740/gr1516. Epub 2022 Apr 15.
5
Prognostic Significance of EMVI in Rectal Cancer in a Tertiary Cancer Hospital in India.印度一家三级癌症医院中EMVI在直肠癌中的预后意义
Indian J Radiol Imaging. 2021 Oct 26;31(3):560-565. doi: 10.1055/s-0041-1736404. eCollection 2021 Jul.
6
MRI features of signet ring rectal cancer.直肠印戒细胞癌的 MRI 特征。
Abdom Radiol (NY). 2021 Dec;46(12):5536-5549. doi: 10.1007/s00261-021-03250-1. Epub 2021 Aug 24.
7
Outcomes of Definitive Treatment of Signet Ring Cell Carcinoma of the Rectum: Is Minimal Invasive Surgery Detrimental in Signet Ring Rectal Cancers?直肠印戒细胞癌根治性治疗的结果:微创手术对直肠印戒细胞癌有害吗?
Indian J Surg Oncol. 2020 Dec;11(4):597-603. doi: 10.1007/s13193-020-01142-2. Epub 2020 Aug 3.
8
Trends of incidence and survival in patients with gastroenteropancreatic signet ring cell carcinoma: an analysis from the Surveillance, Epidemiology, and End Results program.胃肠胰印戒细胞癌患者的发病率及生存率趋势:来自监测、流行病学和最终结果计划的分析
J Gastrointest Oncol. 2019 Oct;10(5):979-988. doi: 10.21037/jgo.2019.06.07.
9
Demographic and Clinicopathological Patterns of Colorectal Cancer at the National Cancer Institute, Sudan.苏丹国家癌症研究所结直肠癌的人口统计学和临床病理特征
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):146-150. doi: 10.4103/sjmms.sjmms_138_18. Epub 2019 Aug 28.
10
Adjuvant chemotherapy in stage II-III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX.来自一个结肠癌患病率较低国家的非试验队列中接受手术的II-III期结肠癌患者的辅助化疗,主要采用改良的CAPOX方案。
South Asian J Cancer. 2019 Jul-Sep;8(3):160-165. doi: 10.4103/sajc.sajc_176_18.

本文引用的文献

1
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.辅助性热灌注腹腔化疗(HIPEC)用于有腹膜播散高危风险的结肠癌患者;COLOPEC随机多中心试验
BMC Cancer. 2015 May 24;15:428. doi: 10.1186/s12885-015-1430-7.
2
Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status.根据EPCAM表达状态区分微卫星不稳定型结直肠癌的特征
Korean J Pathol. 2014 Aug;48(4):276-82. doi: 10.4132/KoreanJPathol.2014.48.4.276. Epub 2014 Aug 26.
3
Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology.印戒细胞组织学类型的结直肠癌腹膜转移癌患者接受细胞减灭术和腹腔热灌注化疗后的预后较差。
J Surg Oncol. 2015 Feb;111(2):237-42. doi: 10.1002/jso.23784. Epub 2014 Sep 5.
4
Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases.对有腹膜转移高风险的结肠癌患者进行局部区域控制的积极管理后的长期结果。
Int J Colorectal Dis. 2014 Sep;29(9):1081-9. doi: 10.1007/s00384-014-1929-4. Epub 2014 Jul 1.
5
Metastatic pattern in colorectal cancer is strongly influenced by histological subtype.结直肠癌的转移模式受组织学亚型的影响很大。
Ann Oncol. 2014 Mar;25(3):651-657. doi: 10.1093/annonc/mdt591. Epub 2014 Feb 6.
6
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis.黏液性和印戒细胞结直肠癌在肿瘤生物学和预后方面与经典腺癌不同。
Ann Surg. 2013 Nov;258(5):775-82; discussion 782-3. doi: 10.1097/SLA.0b013e3182a69f7e.
7
Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol.荷兰的细胞减灭术和 HIPEC:荷兰方案的全国性长期结果。
Ann Surg Oncol. 2013 Dec;20(13):4224-30. doi: 10.1245/s10434-013-3145-9. Epub 2013 Jul 30.
8
A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.用于结肠癌的新型治疗药物:EpCAM scFv 截断鱼精蛋白 (tp)-siRNA。
Cell Biol Int. 2013 Aug;37(8):860-4. doi: 10.1002/cbin.10112. Epub 2013 Apr 30.
9
An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.胃和结直肠原发性印戒细胞癌的免疫组织化学研究:III. 42例正常黏膜及病例中EMA、CEA、CA19-9、CDX-2、p53、Ki-67抗原、TTF-1、波形蛋白和p63的表达
Int J Clin Exp Pathol. 2013;6(4):630-8. Epub 2013 Mar 15.
10
Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.结直肠印戒细胞癌中的杂合性缺失、异常甲基化、BRAF 突变和 KRAS 突变。
Mod Pathol. 2012 Jul;25(7):1040-7. doi: 10.1038/modpathol.2012.44. Epub 2012 Apr 20.